Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 120Lymphoma 90Lymphoma, Large B-Cell, Diffuse 79Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Burkitt Lymphoma 31Leukemia 27Multiple Myeloma 26Lymphoma, Non-Hodgkin 26Lymphoma, Follicular 26Hodgkin Disease 24Lymphoma, Mantle-Cell 18Neoplasms 16Lymphoma, T-Cell, Peripheral 16Lymphoma, B-Cell 14Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, Large-Cell, Anaplastic 11Dendritic Cell Sarcoma, Interdigitating 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Neoplasms, Plasma Cell 7Neoplasm Metastasis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Lymphoma, T-Cell 6Immunoblastic Lymphadenopathy 6HIV Infections 5Graft vs Host Disease 5Blast Crisis 5

Interventions

pegaspargase 15fludarabine phosphate 15Mycophenolic Acid 14Busulfan 14Tacrolimus 13Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 12Etoposide 12Dexamethasone 12Whole-Body Irradiation 11Methotrexate 10Gemcitabine 10Antilymphocyte Serum 9Radiotherapy 7Cyclosporine 7spartalizumab 6Oxaliplatin 5Asparaginase 5Transplantation 4Rituximab 4Melphalan 4Flow Cytometry 4tislelizumab 3thymoglobulin 3sintilimab 3selinexor 3pembrolizumab 3Therapeutics 3Polymerase Chain Reaction 3Cord Blood Stem Cell Transplantation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Extranodal NK-T-Cell × Prednisone × Clear all
NCT00069238 2022-02-24

Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
31 enrolled 12 charts
Lymphoid

Lymphoma, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡